The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Macias William L. since 2022.
This trader's CIK number is 1864280.
At the time of last reporting, Macias William L. was the Chief Medical Officer of Immunovant, Inc.. (stock ticker symbol IMVT).
Also see all insider trading activities at Immunovant, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | IMVT | 0 | $0 | 4,438 | $100,059 | 0 | $0 |
| 2024 | IMVT | 0 | $0 | 26,360 | $785,575 | 0 | $0 |
| 2023 | IMVT | 0 | $0 | 62,168 | $1,120,364 | 0 | $0 |
| 2022 | IMVT | 0 | $0 | 28,868 | $233,753 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-19 | IMVT | Sale | 2,055 | 20.86 | 42,867 |
| 2025-01-15 | IMVT | Sale | 2,383 | 24.00 | 57,192 |
| 2024-11-20 | IMVT | Sale | 3,353 | 25.45 | 85,333 |
| 2024-10-16 | IMVT | Sale | 3,188 | 28.79 | 91,782 |
| 2024-08-21 | IMVT | Sale | 3,027 | 32.08 | 97,106 |
| 2024-07-17 | IMVT | Sale | 3,044 | 30.09 | 91,609 |
| 2024-05-22 | IMVT | Sale | 3,247 | 29.65 | 96,273 |
| 2024-04-17 | IMVT | Sale | 8,280 | 29.37 | 243,183 |
| 2024-02-22 | IMVT | Sale | 2,221 | 36.15 | 80,289 |
| 2023-11-22 | IMVT | Sale | 3,265 | 33.13 | 108,185 |
| 2023-10-19 | IMVT | Sale | 530 | 36.80 | 19,504 |
| 2023-08-24 | IMVT | Sale | 12,333 | 20.59 | 253,998 |
| 2023-07-19 | IMVT | Sale | 426 | 24.94 | 10,624 |
| 2023-04-25 | IMVT | Sale | 509 | 16.29 | 8,291 |
| 2023-02-02 | IMVT | Sale | 537 | 18.24 | 9,794 |
| 2023-01-11 | IMVT | Sale | 44,568 | 15.93 | 709,968 |
| 2022-10-21 | IMVT | Sale | 341 | 9.67 | 3,297 |
| 2022-07-22 | IMVT | Sale | 322 | 4.70 | 1,513 |
| 2022-04-19 | IMVT | Sale | 1,392 | 4.98 | 6,932 |
| 2022-01-05 | IMVT | Sale | 26,813 | 8.28 | 222,011 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Macias William L. (Chief Medical Officer of Immunovant, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.